Cleared Special

K261519 - Sonio Suspect

K261519 is an FDA 510(k) clearance for Sonio Suspect, manufactured by Sonio. The device is a Class 2 Radiology device with product code POK cleared through the Special 510(k) pathway after a 28-day FDA review.

K261519 · Sonio · Radiology device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Jun 2026
Decision
28d
Days
Class 2
Risk

K261519 is an FDA 510(k) clearance for the Sonio Suspect. Classified as Computer-assisted Diagnostic Software For Lesions Suspicious For Cancer (product code POK), Class II - Special Controls.

Submitted by Sonio (Paris, FR). The FDA issued a Cleared decision on June 4, 2026 after a review of 28 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2060 - the FDA radiology and imaging software oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

FDA 510(k) Submission Details - K261519

510(k) Number K261519 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 07, 2026
Decision Date June 04, 2026
Days to Decision 28 days
Submission Type Special
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
79d faster than avg
Panel avg: 107d · This submission: 28d
Pathway characteristics
Modification to existing cleared device.

POK Device Classification - Class 2, Special Controls

Product Code POK Computer-assisted Diagnostic Software For Lesions Suspicious For Cancer
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2060
Definition Assist Users In Characterizing Lesions Identified On Acquired Medical Images
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - POK Computer-assisted Diagnostic Software For Lesions Suspicious For Cancer

All 23
Devices cleared under the same product code (POK) and FDA review panel - the closest regulatory comparables to K261519.
BlineSlide
K261679 · Deep Breathe, Inc. · Oct 2026
Koios DS (3.8)
K253884 · Koios Medical, Inc. · Jul 2026
Automated Aortic Stenosis Software (AutoAS)
K254161 · GE Medical Systems Ultrasound & Primary Care Diagnostics, LLC · Mar 2026
RevealAI-Lung
K251769 · Precision Medical Ventures, Inc. Dba Revealdx · Jan 2026
Fetal EchoScan (v1.2)
K252294 · Brightheart · Dec 2025
StrokeSENS ASPECTS Software Application
K250221 · Circle Cardiovascular Imaging, Inc. · Jul 2025
K261519 · Sonio Suspect
Download PDF FDA Summary Sonio